Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

No skin irritations were observed in an acute dermal toxicity study performed according to OECD testing guideline 402. In an acute eye irritation/corrosion test, performed on rabbits according to OECD testing guideline 405, neither mortalities nor significant clinical signs of toxicity were observed.

Key value for chemical safety assessment

Skin irritation / corrosion

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Additional information

Justification for classification or non-classification

No skin irritations were observed in an acute dermal toxicity study performed according to OECD testing guideline 402. Furthermore,

companies involved in the elaboration of the registration dossier confirmed by certificates of their company doctors that in up to 20 years of manufacturing, handling and use of sulphuric acid, compound with graphite just one case of dermal irritation (i.e. reversible within up to three weeks after exposure) occurred due to exposure of workers to this substance.

In an acute eye irritation/corrosion test, performed on rabbits according to OECD testing guideline 405, neither mortalities nor significant clinical signs of toxicity were observed.

Against this background it can be concluded that sulphuric acid, compound with graphite has no classification obligations according to the CLP Regulation.